0 XP   0   0   0

Valneva SE
Buy, Hold or Sell?

Let's analyse Valneva together

PenkeI guess you are interested in Valneva SE. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Valneva SE. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Valneva SE

I send you an email if I find something interesting about Valneva SE.

Quick analysis of Valneva (30 sec.)










1. Valuation of Valneva (5 min.)




Current price per share

€5.00

2. Growth of Valneva (5 min.)




Is Valneva growing?

Current yearPrevious yearGrowGrow %
How rich?$236.5m$145.4m$19.5m11.8%

How much money is Valneva making?

Current yearPrevious yearGrowGrow %
Making money-$38.5m-$64.4m$25.8m?
Net Profit Margin-79.1%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Valneva (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#252 / 1215

Most Revenue
#87 / 1215

Most Profit
#1017 / 1215

Most Efficient
#684 / 1215


Fundamentals of Valneva

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Valneva SE.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Valneva earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • A Net Profit Margin of -39.7% means that €-0.40 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Valneva SE:

  • The MRQ is -39.7%. The company is making a huge loss. -2
  • The TTM is -79.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-39.7%TTM-79.1%+39.4%
TTM-79.1%YOY--79.1%
TTM-79.1%5Y-18.0%-61.2%
5Y-18.0%10Y-18.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.7%-194.7%+155.0%
TTM-79.1%-272.1%+193.0%
YOY--303.9%+303.9%
5Y-18.0%-539.0%+521.0%
10Y-18.0%-661.6%+643.6%
1.1.2. Return on Assets

Shows how efficient Valneva is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • -7.1% Return on Assets means that Valneva generated €-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Valneva SE:

  • The MRQ is -7.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.1%TTM-6.7%-0.5%
TTM-6.7%YOY-22.6%+16.0%
TTM-6.7%5Y-7.5%+0.8%
5Y-7.5%10Y-7.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.1%-12.6%+5.5%
TTM-6.7%-12.6%+5.9%
YOY-22.6%-10.9%-11.7%
5Y-7.5%-15.3%+7.8%
10Y-7.5%-17.7%+10.2%
1.1.3. Return on Equity

Shows how efficient Valneva is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • -20.1% Return on Equity means Valneva generated €-0.20 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Valneva SE:

  • The MRQ is -20.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -37.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.1%TTM-37.9%+17.8%
TTM-37.9%YOY-44.3%+6.4%
TTM-37.9%5Y-19.9%-17.9%
5Y-19.9%10Y-19.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.1%-15.3%-4.8%
TTM-37.9%-15.6%-22.3%
YOY-44.3%-13.2%-31.1%
5Y-19.9%-20.5%+0.6%
10Y-19.9%-20.9%+1.0%

1.2. Operating Efficiency of Valneva SE.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Valneva is operating .

  • Measures how much profit Valneva makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Valneva SE:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-83.7%+83.7%
TTM-83.7%YOY--83.7%
TTM-83.7%5Y-18.5%-65.2%
5Y-18.5%10Y-18.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--313.9%+313.9%
TTM-83.7%-265.1%+181.4%
YOY--331.0%+331.0%
5Y-18.5%-515.2%+496.7%
10Y-18.5%-609.4%+590.9%
1.2.2. Operating Ratio

Measures how efficient Valneva is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.60 means that the operating costs are €2.60 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Valneva SE:

  • The MRQ is 2.598. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.684. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.598TTM2.684-0.086
TTM2.684YOY-+2.684
TTM2.6845Y1.196+1.488
5Y1.19610Y1.1960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5983.013-0.415
TTM2.6843.644-0.960
YOY-4.501-4.501
5Y1.1966.353-5.157
10Y1.1968.330-7.134

1.3. Liquidity of Valneva SE.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Valneva is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.53 means the company has €1.53 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Valneva SE:

  • The MRQ is 1.531. The company is able to pay all its short-term debts. +1
  • The TTM is 1.365. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.531TTM1.365+0.166
TTM1.365YOY1.427-0.062
TTM1.3655Y2.142-0.777
5Y2.14210Y2.1420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5314.571-3.040
TTM1.3655.011-3.646
YOY1.4276.142-4.715
5Y2.1426.306-4.164
10Y2.1426.588-4.446
1.3.2. Quick Ratio

Measures if Valneva is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • A Quick Ratio of 0.09 means the company can pay off €0.09 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Valneva SE:

  • The MRQ is 0.086. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.087. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.086TTM0.0870.000
TTM0.087YOY0.089-0.002
TTM0.0875Y0.228-0.141
5Y0.22810Y0.2280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0863.923-3.837
TTM0.0874.516-4.429
YOY0.0895.772-5.683
5Y0.2285.816-5.588
10Y0.2286.032-5.804

1.4. Solvency of Valneva SE.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Valneva assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Valneva to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.65 means that Valneva assets are financed with 64.6% credit (debt) and the remaining percentage (100% - 64.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Valneva SE:

  • The MRQ is 0.646. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.693. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.646TTM0.693-0.046
TTM0.693YOY0.489+0.203
TTM0.6935Y0.522+0.171
5Y0.52210Y0.5220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6460.311+0.335
TTM0.6930.298+0.395
YOY0.4890.269+0.220
5Y0.5220.377+0.145
10Y0.5220.409+0.113
1.4.2. Debt to Equity Ratio

Measures if Valneva is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Valneva to the Biotechnology industry mean.
  • A Debt to Equity ratio of 182.7% means that company has €1.83 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Valneva SE:

  • The MRQ is 1.827. The company is just able to pay all its debts with equity.
  • The TTM is 3.198. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ1.827TTM3.198-1.371
TTM3.198YOY0.959+2.239
TTM3.1985Y1.395+1.803
5Y1.39510Y1.3950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8270.362+1.465
TTM3.1980.361+2.837
YOY0.9590.277+0.682
5Y1.3950.425+0.970
10Y1.3950.460+0.935

2. Market Valuation of Valneva SE

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Valneva generates.

  • Above 15 is considered overpriced but always compare Valneva to the Biotechnology industry mean.
  • A PE ratio of -19.71 means the investor is paying €-19.71 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Valneva SE:

  • The EOD is -15.635. Company is losing money. -2
  • The MRQ is -19.706. Company is losing money. -2
  • The TTM is -25.938. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-15.635MRQ-19.706+4.071
MRQ-19.706TTM-25.938+6.232
TTM-25.938YOY109.429-135.367
TTM-25.9385Y-664.705+638.767
5Y-664.70510Y-664.7050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.635-6.313-9.322
MRQ-19.706-7.248-12.458
TTM-25.938-8.522-17.416
YOY109.429-19.704+129.133
5Y-664.705-18.354-646.351
10Y-664.705-18.137-646.568
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Valneva.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Valneva SE:

  • The MRQ is 32.284. Seems overpriced? -1
  • The TTM is 15.013. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ32.284TTM15.013+17.271
TTM15.013YOY125.599-110.586
TTM15.0135Y-358.181+373.194
5Y-358.18110Y-358.1810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ32.284-4.301+36.585
TTM15.013-6.130+21.143
YOY125.599-13.925+139.524
5Y-358.181-12.463-345.718
10Y-358.181-11.860-346.321

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Valneva is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.96 means the investor is paying €3.96 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Valneva SE:

  • The EOD is 3.144. Neutral. Compare to industry.
  • The MRQ is 3.963. Neutral. Compare to industry.
  • The TTM is 10.122. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD3.144MRQ3.963-0.819
MRQ3.963TTM10.122-6.159
TTM10.122YOY15.392-5.270
TTM10.1225Y7.931+2.191
5Y7.93110Y7.9310.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.1441.808+1.336
MRQ3.9632.028+1.935
TTM10.1222.338+7.784
YOY15.3923.951+11.441
5Y7.9313.697+4.234
10Y7.9313.952+3.979
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Valneva SE compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3970.153+159%-+100%0.042+833%0.042+833%
Book Value Growth--1.3321.198+11%1.000+33%1.061+26%1.061+26%
Book Value Per Share--1.5901.109+43%0.978+63%0.974+63%0.974+63%
Book Value Per Share Growth--1.3321.198+11%1.000+33%1.061+26%1.061+26%
Current Ratio--1.5311.365+12%1.427+7%2.142-29%2.142-29%
Debt To Asset Ratio--0.6460.693-7%0.489+32%0.522+24%0.522+24%
Debt To Equity Ratio--1.8273.198-43%0.959+91%1.395+31%1.395+31%
Dividend Per Share----0%-0%-0%-0%
Eps---0.320-0.259-19%-0.433+35%-0.170-47%-0.170-47%
Eps Growth---0.610-1.428+134%-2.563+320%-0.150-75%-0.150-75%
Free Cash Flow Per Share---0.453-0.497+10%-0.113-75%-0.082-82%-0.082-82%
Free Cash Flow Per Share Growth--1.3460.686+96%-0.727+154%3.039-56%3.039-56%
Free Cash Flow To Equity Per Share--0.223-0.108+148%0.090+148%0.062+262%0.062+262%
Free Cash Flow To Equity Per Share Growth--2.390-0.704+129%1.254+91%1.728+38%1.728+38%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--50.626--------
Intrinsic Value_10Y_min--27.928--------
Intrinsic Value_1Y_max--0.284--------
Intrinsic Value_1Y_min---1.182--------
Intrinsic Value_3Y_max--4.503--------
Intrinsic Value_3Y_min---0.124--------
Intrinsic Value_5Y_max--13.122--------
Intrinsic Value_5Y_min--4.680--------
Net Profit Margin---0.397-0.791+99%--100%-0.180-55%-0.180-55%
Operating Margin----0.8370%-0%-0.1850%-0.1850%
Operating Ratio--2.5982.684-3%-+100%1.196+117%1.196+117%
Pb Ratio3.144-26%3.96310.122-61%15.392-74%7.931-50%7.931-50%
Pe Ratio-15.635+21%-19.706-25.938+32%109.429-118%-664.705+3273%-664.705+3273%
Peg Ratio--32.28415.013+115%125.599-74%-358.181+1209%-358.181+1209%
Price Per Share5.000-26%6.3029.533-34%15.050-58%7.493-16%7.493-16%
Price To Total Gains Ratio12.608-26%15.892-3.160+120%---454.929+2963%-454.929+2963%
Profit Growth---0.610-1.428+134%-2.563+320%-0.150-75%-0.150-75%
Quick Ratio--0.0860.087-1%0.089-3%0.228-62%0.228-62%
Return On Assets---0.071-0.067-6%-0.226+218%-0.075+5%-0.075+5%
Return On Equity---0.201-0.379+88%-0.443+120%-0.199-1%-0.199-1%
Revenue Growth--0.7112.058-65%--1.381-49%1.381-49%
Total Gains Per Share--0.3970.153+159%-+100%0.042+833%0.042+833%
Total Gains Per Share Growth--0.7642.238-66%--7.370-90%7.370-90%
Usd Book Value--236523551.700164962901.700+43%145438143.300+63%144818139.789+63%144818139.789+63%
Usd Book Value Change Per Share--0.4270.165+159%-+100%0.046+833%0.046+833%
Usd Book Value Per Share--1.7111.193+43%1.052+63%1.048+63%1.048+63%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.344-0.279-19%-0.466+35%-0.183-47%-0.183-47%
Usd Free Cash Flow---67375697.100-73891751.625+10%-16873786.050-75%-12131271.758-82%-12131271.758-82%
Usd Free Cash Flow Per Share---0.487-0.535+10%-0.122-75%-0.088-82%-0.088-82%
Usd Free Cash Flow To Equity Per Share--0.240-0.116+148%0.097+148%0.066+262%0.066+262%
Usd Price Per Share5.381-26%6.78210.258-34%16.195-58%8.063-16%8.063-16%
Usd Profit---47567924.400-38545632.975-19%-64416960.150+35%-25319896.721-47%-25319896.721-47%
Usd Revenue--119878616.10097199539.575+23%-+100%32195326.168+272%32195326.168+272%
Usd Total Gains Per Share--0.4270.165+159%-+100%0.046+833%0.046+833%
 EOD+2 -3MRQTTM+28 -10YOY+26 -95Y+17 -2110Y+17 -21

3.2. Fundamental Score

Let's check the fundamental score of Valneva SE based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-15.635
Price to Book Ratio (EOD)Between0-13.144
Net Profit Margin (MRQ)Greater than0-0.397
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.086
Current Ratio (MRQ)Greater than11.531
Debt to Asset Ratio (MRQ)Less than10.646
Debt to Equity Ratio (MRQ)Less than11.827
Return on Equity (MRQ)Greater than0.15-0.201
Return on Assets (MRQ)Greater than0.05-0.071
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Valneva SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.379
Ma 20Greater thanMa 505.549
Ma 50Greater thanMa 1005.068
Ma 100Greater thanMa 2005.581
OpenGreater thanClose5.250
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets621,344
Total Liabilities401,547
Total Stockholder Equity219,797
 As reported
Total Liabilities 401,547
Total Stockholder Equity+ 219,797
Total Assets = 621,344

Assets

Total Assets621,344
Total Current Assets424,659
Long-term Assets424,659
Total Current Assets
Cash And Cash Equivalents 289,430
Net Receivables 23,912
Inventory 35,104
Other Current Assets 74,079
Total Current Assets  (as reported)424,659
Total Current Assets  (calculated)422,525
+/- 2,134
Long-term Assets
Intangible Assets 28,711
Long-term Assets Other 8,299
Long-term Assets  (as reported)196,685
Long-term Assets  (calculated)37,010
+/- 159,675

Liabilities & Shareholders' Equity

Total Current Liabilities277,393
Long-term Liabilities124,154
Total Stockholder Equity219,797
Total Current Liabilities
Short Long Term Debt 11,580
Accounts payable 41,491
Other Current Liabilities 141,973
Total Current Liabilities  (as reported)277,393
Total Current Liabilities  (calculated)195,044
+/- 82,349
Long-term Liabilities
Long term Debt 87,227
Capital Lease Obligations Min Short Term Debt53,574
Long-term Liabilities Other 6,750
Long-term Liabilities  (as reported)124,154
Long-term Liabilities  (calculated)147,551
+/- 23,397
Total Stockholder Equity
Total Stockholder Equity (as reported)219,797
Total Stockholder Equity (calculated)0
+/- 219,797
Other
Capital Stock20,755
Common Stock Shares Outstanding 138,223
Net Invested Capital 318,604
Net Working Capital 147,266



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302012-12-312012-09-302012-06-302012-03-31
> Total Assets 
235,157
263,500
252,130
241,173
181,475
175,338
229,907
243,742
249,143
250,649
264,723
0
0
0
0
0
0
0
0
0
725,105
698,083
621,344
621,344698,083725,105000000000264,723250,649249,143243,742229,907175,338181,475241,173252,130263,500235,157
   > Total Current Assets 
78,861
115,267
102,322
89,748
79,524
74,009
125,972
117,483
121,860
118,932
129,162
142,691
253,446
311,273
308,427
416,981
561,962
585,832
585,832
545,021
503,776
476,535
424,659
424,659476,535503,776545,021585,832585,832561,962416,981308,427311,273253,446142,691129,162118,932121,860117,483125,97274,00979,52489,748102,322115,26778,861
       Cash And Cash Equivalents 
15,137
50,812
34,034
16,001
37,717
33,040
81,725
68,059
69,944
67,387
64,439
0
0
0
0
0
0
0
0
0
336,177
261,042
289,430
289,430261,042336,17700000000064,43967,38769,94468,05981,72533,04037,71716,00134,03450,81215,137
       Short-term Investments 
36,068
0
42,290
43,239
0
32
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000032043,23942,290036,068
       Net Receivables 
13,404
19,087
12,501
20,455
12,810
8,247
11,259
15,056
14,086
9,898
24,030
16,736
7,524
109,203
19,232
25,100
18,007
44,013
44,013
25,061
16,251
57,732
23,912
23,91257,73216,25125,06144,01344,01318,00725,10019,232109,2037,52416,73624,0309,89814,08615,05611,2598,24712,81020,45512,50119,08713,404
       Inventory 
14,252
11,693
13,495
10,052
20,206
22,985
22,727
23,247
24,589
26,986
25,772
28,117
30,494
28,394
26,933
97,400
125,664
124,098
124,098
139,725
95,201
96,462
35,104
35,10496,46295,201139,725124,098124,098125,66497,40026,93328,39430,49428,11725,77226,98624,58923,24722,72722,98520,20610,05213,49511,69314,252
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
221,330
221,548
196,685
196,685221,548221,33000000000000000000000
       Property Plant Equipment 
56,837
53,730
53,585
53,694
37,558
37,327
37,997
62,362
63,779
66,517
69,337
66,644
67,647
71,728
78,153
93,622
123,028
173,830
173,830
175,980
169,992
170,659
0
0170,659169,992175,980173,830173,830123,02893,62278,15371,72867,64766,64469,33766,51763,77962,36237,99737,32737,55853,69453,58553,73056,837
       Long Term Investments 
0
33,674
0
0
0
0
1,436
688
1,427
2,384
2,263
0
0
0
0
0
0
0
0
0
0
0
0
0000000000002,2632,3841,4276881,436000033,6740
       Intangible Assets 
84,094
79,869
81,550
82,838
46,613
45,774
42,833
44,223
43,247
42,435
41,813
0
0
0
0
0
0
0
0
0
0
0
28,711
28,7110000000000041,81342,43543,24744,22342,83345,77446,61382,83881,55079,86984,094
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,948
18,294
8,299
8,29918,29417,94800000000000000000000
> Total Liabilities 
121,171
138,660
133,331
132,959
89,533
85,611
86,721
104,554
117,419
119,021
129,570
0
0
0
0
0
0
0
0
0
631,850
533,100
401,547
401,547533,100631,850000000000129,570119,021117,419104,55486,72185,61189,533132,959133,331138,660121,171
   > Total Current Liabilities 
39,132
40,285
38,137
40,861
46,192
41,264
42,944
27,634
39,848
31,547
41,300
45,132
104,723
201,936
175,870
320,357
456,917
368,979
368,979
363,257
436,128
374,211
277,393
277,393374,211436,128363,257368,979368,979456,917320,357175,870201,936104,72345,13241,30031,54739,84827,63442,94441,26446,19240,86138,13740,28539,132
       Short-term Debt 
18,405
21,397
18,858
19,015
22,957
20,032
16,664
1,998
1,935
2,029
1,999
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,9992,0291,9351,99816,66420,03222,95719,01518,85821,39718,405
       Short Long Term Debt 
18,405
21,397
18,858
19,015
22,957
20,032
16,664
1,998
1,935
2,029
1,999
0
0
0
0
0
0
0
0
0
11,543
12,494
11,580
11,58012,49411,5430000000001,9992,0291,9351,99816,66420,03222,95719,01518,85821,39718,405
       Accounts payable 
15,253
14,100
14,683
17,851
11,353
9,189
9,175
10,113
14,994
13,246
8,868
17,491
19,778
13,968
24,898
60,878
71,502
16,035
16,035
66,268
83,704
74,973
41,491
41,49174,97383,70466,26816,03516,03571,50260,87824,89813,96819,77817,4918,86813,24614,99410,1139,1759,18911,35317,85114,68314,10015,253
       Other Current Liabilities 
5,472
4,786
4,597
3,995
3,843
4,225
3,447
4,429
12,311
5,448
9,802
9,043
64,488
167,073
116,809
239,152
375,247
273,369
273,369
262,299
322,693
267,590
141,973
141,973267,590322,693262,299273,369273,369375,247239,152116,809167,07364,4889,0439,8025,44812,3114,4293,4474,2253,8433,9954,5974,7865,472
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
195,722
158,888
124,154
124,154158,888195,72200000000000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,920
55,761
53,574
53,57455,76154,92000000000000000000000
       Other Liabilities 
165
0
0
0
4,311
4,032
3,707
4,638
7,548
7,405
7,360
7,439
70,839
70,302
100,105
103,939
109,802
173,379
173,379
165,380
76,733
12,882
0
012,88276,733165,380173,379173,379109,802103,939100,10570,30270,8397,4397,3607,4057,5484,6383,7074,0324,311000165
> Total Stockholder Equity
113,986
124,839
118,798
108,214
91,942
89,727
143,186
139,188
131,724
131,628
135,153
0
0
0
0
0
0
0
0
0
93,255
164,983
219,797
219,797164,98393,255000000000135,153131,628131,724139,188143,18689,72791,942108,214118,798124,839113,986
   Common Stock
64,710
70,031
70,994
72,755
11,638
11,638
13,638
13,638
13,638
13,641
13,642
13,642
13,642
13,643
13,646
13,765
14,986
15,786
15,786
16,170
17,603
17,603
0
017,60317,60316,17015,78615,78614,98613,76513,64613,64313,64213,64213,64213,64113,63813,63813,63811,63811,63872,75570,99470,03164,710
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
33,129
30,266
32,376
33,554
0
0
47,340
-1
0
0
47,984
0
-1
7,131
62,713
52,767
63,507
62,673
62,673
52,452
62,643
51,791
0
051,79162,64352,45262,67362,67363,50752,76762,7137,131-1047,98400-147,3400033,55432,37630,26633,129



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue361,303
Cost of Revenue-324,441
Gross Profit36,86236,862
 
Operating Income (+$)
Gross Profit36,862
Operating Expense-474,746
Operating Income-113,443-437,884
 
Operating Expense (+$)
Research Development104,922
Selling General Administrative57,582
Selling And Marketing Expenses-
Operating Expense474,746162,504
 
Net Interest Income (+$)
Interest Income260
Interest Expense-19,054
Other Finance Cost-0
Net Interest Income-18,794
 
Pretax Income (+$)
Operating Income-113,443
Net Interest Income-18,794
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-144,815-100,865
EBIT - interestExpense = -19,054
-143,279
-124,225
Interest Expense19,054
Earnings Before Interest and Taxes (EBIT)--125,761
Earnings Before Interest and Taxes (EBITDA)-125,761
 
After tax Income (+$)
Income Before Tax-144,815
Tax Provision--1,536
Net Income From Continuing Ops-143,279-143,279
Net Income-143,279
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-12,57818,794
 

Technicals of Valneva

1. Trend Indicators

1.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Valneva SE Daily Moving Averages ChartValneva SE Daily Moving Averages Chart
1.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Let's take a look of the Moving Average Convergence/Divergence (MACD) of Valneva SE:

  • The Moving Average Convergence/Divergence (MACD) is 0.065. The Moving Average Convergence/Divergence (MACD) above zero is a bullish sign. +1
  • The MACD is lower than the signal line. This is a bearish indication. -1
Valneva SE Daily Moving Average Convergence/Divergence (MACD) ChartValneva SE Daily Moving Average Convergence/Divergence (MACD) Chart
1.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index).

The ADX helps you determine the strength of a trend. Let's take a look of the ADX of Valneva SE:

  • The ADX is 28.134. Strong Trend. +1
  • The ADX is declining, the current trend is weakening. -1
  • The +DI crossed the -DI to the downside. The trend is reversing to a down trend. -1
Valneva SE Daily Directional Movement Index (DMI) ChartValneva SE Daily Directional Movement Index (DMI) Chart
1.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..
  • The Parabolic SAR is higher than the price. The current trend is down. -2
  • Valneva SE Daily Parabolic SAR ChartValneva SE Daily Parabolic SAR Chart

    2. Momentum Indicators

    2.1 Relative Strength Index (RSI)

    Measures the speed and change of price movements.

    • Leading momentum indicator, meaning the signals are instant.
    • Ranges between 0 and 100.
    • Above 70 is considered overbought.
    • Below 30 is considered oversold.
    • Above or below 50 can also be used to determine price trend or support and resistance.
    • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
    • Can be used in many different ways
    • The RSI is below 50. -1
    Valneva SE Daily Relative Strength Index (RSI) ChartValneva SE Daily Relative Strength Index (RSI) Chart
    2.2 Stochastic Oscillator

    Compares a certain price to multiple prices ranging over time.

    • Leading momentum indicator, meaning the signals are instant.
    • Used to determine overbought and oversold areas much like the RSI.
    • Ranges between 0 and 100.
    • Above 80 is considered overbought.
    • Below 20 is considered oversold.
    • Consists of two lines named K and D.
    • K compares the highest high and lowest low on the selected price range.
    • The D line is a moving average of the K line.
    • Can be used to spot divergences
    • The Stochastic is below 50. -1
    • The Stochastic is below 30 and oversold. +2
    Valneva SE Daily Stochastic Oscillator ChartValneva SE Daily Stochastic Oscillator Chart
    2.3 Commodity Channel Index (CCI)
    Valneva SE Daily Commodity Channel Index (CCI) ChartValneva SE Daily Commodity Channel Index (CCI) Chart
    2.4 Chande Momentum Oscillator (CMO)
    Valneva SE Daily Chande Momentum Oscillator (CMO) ChartValneva SE Daily Chande Momentum Oscillator (CMO) Chart
    2.5 Williams %R
    Valneva SE Daily Williams %R ChartValneva SE Daily Williams %R Chart

    3. Volatility Indicators

    3.1 Bollinger Bands
    Valneva SE Daily Bollinger Bands ChartValneva SE Daily Bollinger Bands Chart
    3.2 Average True Range (ATR)
    Valneva SE Daily Average True Range (ATR) ChartValneva SE Daily Average True Range (ATR) Chart

    4. Volume Indicators

    4.1 On-Balance Volume (OBV)
    Valneva SE Daily On-Balance Volume (OBV) ChartValneva SE Daily On-Balance Volume (OBV) Chart
    4.2 Money Flow Index (MFI)
    Valneva SE Daily Money Flow Index (MFI) ChartValneva SE Daily Money Flow Index (MFI) Chart

    5. Summary

    5.1. Notifications

    TypeNotificationDate
    PenkeCurrently no notifications for Valneva SE.

    5.2. Trading Signals

    DateIndicatorEntry signalExit signal
    2023-05-18STOCH SHORT ENTRY LONG CLOSE80 crossover to downside
    2023-05-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
    2023-05-24STOCH LONG ENTRY SHORT CLOSE20 crossover to upside
    ATR LONG ENTRY SHORT CLOSE
    2023-05-25MACD SHORT ENTRY LONG CLOSE
    2023-05-26ATR LONG ENTRY SHORT CLOSE
    2023-05-29SAR LONG ENTRY SHORT CLOSEprice crossed sar to upside
    2023-05-30DMI LONG ENTRY SHORT CLOSE
    ATR LONG ENTRY SHORT CLOSE

    5.2. Technical Score

    Let's check the technical score of Valneva SE based on Penke's default Symbol scanner.

    Penke's Symbol Scanner

      
      
    IndicatorConditionValue
    RsiGreater than5040.379
    Ma 20Greater thanMa 505.549
    Ma 50Greater thanMa 1005.068
    Ma 100Greater thanMa 2005.581
    OpenGreater thanClose5.250
    Total2/5 (40.0%)

    Comments

    Join the conversation.

    Leave a comment

    Stay informed about Valneva SE.

    Receive notifications about Valneva SE in your mailbox!

    Penke's Market Notifications
    TYM.LSE
    4 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of TYM.LSE.

    TYM.LSE Daily Candlestick Chart
    0MJX.LSE
    9 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of 0MJX.LSE.

    0MJX.LSE Daily Candlestick Chart
    UC46.LSE
    9 minutes ago

    I found you a Golden Cross on the daily chart of UC46.LSE.

    UC46.LSE Daily Candlestick Chart
    WIN.LSE
    11 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of WIN.LSE.

    WIN.LSE Daily Candlestick Chart
    3LNV.LSE
    19 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3LNV.LSE.

    3LNV.LSE Daily Candlestick Chart
    PXS.LSE
    19 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of PXS.LSE.

    PXS.LSE Daily Candlestick Chart
    EDL.LSE
    19 minutes ago

    I found you a STOCH Bearish Reversal Divergence on the daily chart of EDL.LSE.

    EDL.LSE Daily Candlestick Chart
    ANXU.LSE
    19 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of ANXU.LSE.

    ANXU.LSE Daily Candlestick Chart
    CRPR.LSE
    23 minutes ago

    I found you a STOCH Bullish Hidden Divergence on the daily chart of CRPR.LSE.

    CRPR.LSE Daily Candlestick Chart
    SIXC.INDX
    23 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of SIXC.INDX.

    SIXC.INDX Daily Candlestick Chart
    TMIP.LSE
    28 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of TMIP.LSE.

    TMIP.LSE Daily Candlestick Chart
    PANR.LSE
    28 minutes ago

    I found you a RSI Bullish Reversal Divergence on the daily chart of PANR.LSE.

    PANR.LSE Daily Candlestick Chart
    IBGS.LSE
    42 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of IBGS.LSE.

    IBGS.LSE Daily Candlestick Chart
    SPLRCU.INDX
    44 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of SPLRCU.INDX.

    SPLRCU.INDX Daily Candlestick Chart
    S5TELS.INDX
    44 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of S5TELS.INDX.

    S5TELS.INDX Daily Candlestick Chart
    BMY.LSE
    44 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of BMY.LSE.

    BMY.LSE Daily Candlestick Chart
    VNIMC.INDX
    58 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of VNIMC.INDX.

    VNIMC.INDX Daily Candlestick Chart
    QPT.V
    59 minutes ago

    I found you a MACD Bearish Reversal Divergence on the daily chart of QPT.V.

    QPT.V Daily Candlestick Chart
    INX.V
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of INX.V.

    INX.V Daily Candlestick Chart
    CHANDRIMA.BSE
    1 hour ago

    I found you a STOCH Bullish Hidden Divergence on the daily chart of CHANDRIMA.BSE.

    CHANDRIMA.BSE Daily Candlestick Chart
    HDFCMID150.BSE
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of HDFCMID150.BSE.

    HDFCMID150.BSE Daily Candlestick Chart
    XGH.F
    1 hour ago

    I found you a MACD Bearish Hidden Divergence on the daily chart of XGH.F.

    XGH.F Daily Candlestick Chart
    WIC.F
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of WIC.F.

    WIC.F Daily Candlestick Chart
    VS1.F
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of VS1.F.

    VS1.F Daily Candlestick Chart
    UUU.F
    2 hours ago

    I found you a STOCH Bullish Reversal Divergence on the daily chart of UUU.F.

    UUU.F Daily Candlestick Chart